The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
Open accessAbstract
Ependymomas are common childhood brain tumours that occur throughout the nervous system, but are most common in the paediatric hindbrain. Current standard therapy comprises surgery and radiation, but not cytotoxic chemotherapy as it does not further increase survival. Whole-genome and whole-exome sequencing of 47 hindbrain ependymomas reveals an extremely low mutation rate, and zero significant recurrent somatic single nucleotide variants. Although devoid of recurrent single nucleotide variants and focal copy number aberrations, poor-prognosis hindbrain ependymomas exhibit a CpG island methylator phenotype. Transcriptional silencing driven by CpG methylation converges exclusively on targets of the Polycomb repressive complex 2 which represses expression of differentiation genes through trimethylation of H3K27. CpG island methylator phenotype-positive hindbrain ependymomas are responsive to clinical drugs that target either DNA or H3K27 methylation both in vitro and in vivo. We conclude that epigenetic modifiers are the first rational therapeutic candidates for this deadly malignancy, which is epigenetically deregulated but genetically bland.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“many of the enzymes targeted, particularly lysine and arginine methyltransferases, have non-histone substrates”
From The roles of DNA, RNA and histone methylation in ageing and cancer (2019) · cites this paper as [183]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Román‐Gómez, J., Jiménez‐Velasco, A., Agirre, X., Prósper, F., Heiniger, A., & Torres, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.4944 · Cited by 128
RetractedComprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,927
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Self-citationThe Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Self-citationComprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Self-citationDriver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
Self-citationA landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,571
Cited by
Sorted by citations
Items 401–500 of 608
Malgulwar, P. B., Nambirajan, A., Singh, M., Suri, V. S., Sarkar, C., & Sharma, M. C. (2019) · Pathology & Oncology Research · doi:10.1007/s12253-019-00736-8 · Cited by 6
Prognostic value of H3K27me3 in children with ependymoma
Han, Z., Kang, P., Zhang, H., Liao, Z., Li, C., Gong, J., Liu, W., & Tian, Y. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.28121 · Cited by 6
Understanding the epigenetic landscape and cellular architecture of childhood brain tumors
Cruzeiro, G. A. V., Rota, C., Hack, O. A., Segal, R. A., & Filbin, M. G. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104940 · Cited by 7
Harnessing brain development to understand brain tumours
Marino, S., & Gilbertson, R. J. (2021) · Development · doi:10.1242/dev.193342 · Cited by 7
Molecular Biology of Pediatric Brain Tumors and Impact on Novel Therapies
Hoffman, L. M., Salloum, R., & Fouladi, M. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0532-6 · Cited by 6
Complications following resection of primary and recurrent pediatric posterior fossa ependymoma
Malhotra, A. K., Nobre, L. F., Ibrahim, G. M., Kulkarni, A. V., Drake, J. M., Rutka, J. T., Taylor, M. D., Ramaswamy, V., Dirks, P. B., & Dewan, M. C. (2024) · Journal of Neurosurgery Pediatrics · doi:10.3171/2023.11.peds23364 · Cited by 5
Self-citationEpigenetic deprogramming by disruption of CIZ1-RNA nuclear assemblies in early-stage breast cancers
Turvey, G. L., de Alba, E. L., Stewart, E., Cook, H., Alalti, A., Gawne, R. T., Ainscough, J., Mason, A. S., & Coverley, D. (2025) · The Journal of Cell Biology · doi:10.1083/jcb.202409123 · Cited by 5
Dynamics and Function of DNA Methylation During Development
Lennartsson, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803395-1.00003-4 · Cited by 5
Phase II study of everolimus for recurrent or progressive pediatric ependymoma
Bowers, D. C., Rajaram, V., Karajannis, M. A., Gardner, S. L., Su, J. M. F., Baxter, P. A., Partap, S., & Klesse, L. J. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad011 · Cited by 5
Wang, B., Yan, M., Han, B. R., Liu, X., & Liu, P. (2024) · Neurosurgery · doi:10.1227/neu.0000000000002923 · Cited by 5
The Molecular Basis of Pediatric Brain Tumors: A Review with Clinical Implications
Antoniades, E., Keffes, N., Vorri, S. C., Tsitouras, V., Gkantsinikoudis, N., Tsitsopoulos, P., & Magras, J. (2025) · Cancers · doi:10.3390/cancers17091566 · Cited by 5
Weighing ependymoma as an epigenetic disease
Stuckert, A. J., Bertrand, K. C., Wang, P., Smith, A., & Mack, S. C. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03562-0 · Cited by 5
Self-citationPerruccio, K., Mastronuzzi, A., Lupattelli, M., Arcioni, F., Capolsini, I., Cerri, C., Gurdo, G., Massei, M. S., Mastrodicasa, E., & Caniglia, M. (2021) · Reports — Medical Cases Images and Videos · doi:10.3390/reports4020012 · Cited by 5
The Role of Epigenetics in Brain and Spinal Cord Tumors
Park, S. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-14732-6_8 · Cited by 5
Rapid autopsy of a patient with recurrent anaplastic ependymoma
Lange, K. R., Fischer, C., Rajappa, P., Connors, S. W., Pisapia, D. J., Greenfield, J. P., Beltran, H., Rubin, M. A., Mosquera, J. M., & Khakoo, Y. (2017) · Palliative & Supportive Care · doi:10.1017/s1478951517000864 · Cited by 5
Primary Brain Tumors in Childhood
Richterová, R., & Kolarovszki, B. (2018) · InTech eBooks · doi:10.5772/intechopen.74510 · Cited by 5
Origin and Mechanisms of DNA Methylation Dynamics in Cancers
Easwaran, H., & Baylin, S. B. (2019) · RNA technologies · doi:10.1007/978-3-030-14792-1_2 · Cited by 5
Cho, H. J., Park, H. Y., Kim, K., Chae, H., Paek, S. H., Kim, S., Park, C., Choi, S.-H., & Park, S. (2021) · Molecular and Clinical Oncology · doi:10.3892/mco.2021.2250 · Cited by 5
An alternative model for (breast) cancer predisposition
Teugels, E., & Brakeleer, S. D. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0017-7 · Cited by 5
Issa, J. J. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000285 · Cited by 5
Aberrant histone modifications in pediatric brain tumors
Hamanishi, E. T., Dang, D., & Venneti, S. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1587157 · Cited by 4
The Intersection of Epigenetic Alterations and Developmental State in Pediatric Ependymomas
Kardian, A., & Mack, S. C. (2024) · Developmental Neuroscience · doi:10.1159/000537694 · Cited by 4
Self-citationCassim, A., Colino‐Sanguino, Y., Fox, S. L., de la Fuente, L. R., Hartley, H. E., & Valdés‐Mora, F. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10284-0 · Cited by 8
Ghasemi, D. R., Obrecht, D., Wallgren, K., Schuhmann, M. U., Timmermann, B., Rutkowski, S., Schüller, U., & Pajtler, K. W. (2026) · Neuro-Oncology · doi:10.1093/neuonc/noag016 · Cited by 4
Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma
Zhang, J., Ong, W., Rasnitsyn, A., Gonzalez, R. D., Gutierrez, R. L., Balin, P., Saadeldin, A. M., Wu, X., Vladoiu, M. C., López, V. S., et al. (2026) · Nature · doi:10.1038/s41586-026-10264-6 · Cited by 4
Self-citationBaibarac, M. A., Burlănescu, T., Stroe, M., Smaranda, I., & Negrila, C. C. (2022) · Polymers · doi:10.3390/polym14214479 · Cited by 4
Ependymoma from Benign to Highly Aggressive Diseases: A Review
Jünger, S. T., Zschernack, V., Messing‐Jünger, M., Timmermann, B., & Pietsch, T. (2024) · Advances and technical standards in neurosurgery · doi:10.1007/978-3-031-53578-9_2 · Cited by 4
Wiehle, L., Raddatz, G., Pusch, S., Gutekunst, J., von Deimling, A., Rodríguez‐Paredes, M., & Lyko, F. (2017) · Cell Stress · doi:10.15698/cst2017.10.106 · Cited by 4
Davis, I. J., & Pattenden, S. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812433-8.00003-4 · Cited by 4
Single cell transcriptomics reveals unique metabolic profiles of ependymoma subgroups
Batchu, S., Patel, K., Yu, S., Mohamed, A. T., & Karsy, M. J. (2022) · Gene · doi:10.1016/j.gene.2022.146278 · Cited by 4
Cancer: More than a geneticist’s Pandora’s box
Saxena, K., Subbalakshmi, A. R., Kulkarni, P., & Jolly, M. K. (2022) · Journal of Biosciences · doi:10.1007/s12038-022-00254-x · Cited by 4
Paparella, R., Caroleo, A. M., Agolini, E., Chillemi, G., Miele, E., Pedace, L., Rinelli, M., Pizzi, S., Boccuto, L., Colafati, G. S., et al. (2022) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62869 · Cited by 4
lncRNA TRHDE-AS1 Correlated with Genomic Landscape and Clinical Outcome in Glioma
Xie, J., Lin, Y., Li, Y., Fang, A., Li, X., Wang, S., & Li, W. (2023) · Genes · doi:10.3390/genes14051052 · Cited by 4
Beekman, R., Kulis, M., & Martín-Subero, J. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800140-0.00009-1 · Cited by 4
de Sousa, G. R., Marie, S. K. N., Oba‐Shinjo, S. M., Ramalho, L. N. Z., Tone, L. G., & Valera, E. T. (2019) · Child s Nervous System · doi:10.1007/s00381-018-04028-5 · Cited by 4
Invited Review: The role and contribution of transcriptional enhancers in brain cancer
Arabzade, A., Stuckert, A. J., Bertrand, K. C., & Mack, S. C. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12612 · Cited by 4
Self-citationMaung, H. M. W., Chan-on, W., Kunkeaw, N., & Khaenam, P. (2019) · EXCLI journal · doi:10.17179/excli2019-1893 · Cited by 4
What Is The Main Cause Of Cancer?
López‐Lázaro, M. (2016) · Cancer Studies and Therapeutics · doi:10.31038/cst.2016112 · Cited by 10
Ependymomas and Choroid Plexus Tumors
Fuller, C. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-44941-0.00008-4 · Cited by 4
Kline, C., Forester, C. M., & Banerjee, A. (2016) · Pediatric oncology · doi:10.1007/978-3-319-30789-3_4 · Cited by 4
Metabolic adaptations underlie epigenetic vulnerabilities in chemoresistant breast cancerPreprint
Deblois, G., Tonekaboni, S. A. M., Kao, Y. I., Tai, F., Liu, X., Ettayebi, I., Guilhamon, P., Fedor, A. N., Grillo, G., Murison, A. J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/286054 · Cited by 4
Self-citationHistone modification as a drug resistance driver in brain tumors ⁎
Xi, G., Mania-Farnell, B. L., Lei, T., & Tomita, T. (2016) · Oncology and Translational Medicine · doi:10.1007/s10330-016-0165-5 · Cited by 3
TET2 promotor methylation and TET2 protein expression in pediatric posterior fossa ependymoma
Pierscianek, D., Teuber‐Hanselmann, S., Ahmadipour, Y., Oppong, M. D., Unteroberdörster, M., Müller, O., Jabbarli, R., Sure, U., Zhu, Y., & Hindy, N. E. (2019) · Neuropathology · doi:10.1111/neup.12615 · Cited by 3
Paik, S., Maule, F., & Gallo, M. (2020) · Genome · doi:10.1139/gen-2020-0097 · Cited by 5
Self-citationThe Causes of Cancer: An Analysis of Avoidable Risk Factors
Sangamithra, A. (2021) · Shanlax International Journal of Economics · doi:10.34293/economics.v9i2.3727 · Cited by 3
The Pathology according to p53 Pathway
Hatano, Y. (2023) · Pathobiology · doi:10.1159/000535203 · Cited by 3
Cola, A. D., Foss, A., Gilbertson, R. J., & Pathania, M. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062722-034650 · Cited by 3
Tumours form without genetic mutations
Classen, A.-K. (2024) · Nature · doi:10.1038/d41586-024-01019-2 · Cited by 3
Cancer-causing somatic mutations: they are neither necessary nor sufficient
Sonnenschein, C., & Soto, A. M. (2018) · Organisms. Journal of Biological Sciences · doi:10.13133/2532-5876_3.12 · Cited by 3
Les épendymomes de l’enfant : actualités diagnostiques et thérapeutiques
Frappaz, D., Vasiljevic, A., Beuriat, P.-A., Alapetite, C., Grill, J., Szathmári, A., & Faure‐Conter, C. (2016) · Bulletin du Cancer · doi:10.1016/j.bulcan.2016.08.006 · Cited by 3
Misregulation of DNA Methylation Regulators in Cancer
Thompson, J. J., & Robertson, K. D. (2017) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-59786-7_5 · Cited by 3
Cancer aetiology and progression: The crucial link between genome, epigenome and metabolome
Ibrahim, S., & Muhammad, F. (2020) · Nigerian Journal of Basic and Clinical Sciences. · doi:10.4103/njbcs.njbcs_2_20 · Cited by 3
Giangaspero, F., Minasi, S., Gianno, F., Alzoubi, H., Antonelli, M., & Buttarelli, F. R. (2020) · Glioma · doi:10.4103/glioma.glioma_20_20 · Cited by 3
JNO special issue: an update on pediatric neuro-oncology
Kilburn, L. B., & Packer, R. J. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03560-2 · Cited by 3
Dominant CIZ1 fragments drive epigenetic instability and are expressed in early stage cancersPreprint
Turvey, G. L., de Alba, E. L., Stewart, E., Byrom, L., Cook, H., Sofi, S., Alalti, A., Ainscough, J., Mason, A. S., Antson, A. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.22.558821 · Cited by 2
Ghalibafian, M., Mirzaei, S., Girinsky, T., Sadeghi, Y., Saffar, A., Ghodsinezhad, N., Elmi, S., & Bouffet, É. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.06.2294 · Cited by 2
Of criminals and cancer: The importance of social bonds and innate morality on cellular societies
Bukkuri, A., & Adler, F. R. (2024) · Cells and Development · doi:10.1016/j.cdev.2024.203964 · Cited by 2
In Vivo Reprogramming Highlights Epigenetic Regulation That Shapes Cancer Hallmarks
Yamada, Y., Sankoda, N., & Yamada, Y. (2025) · Cancer Science · doi:10.1111/cas.70067 · Cited by 2
Thomas, A. G., Chattopadhyay, A., & Dineen, R. A. (2025) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2025.08.008 · Cited by 2
EZHIP boosts neuronal-like synaptic gene programs and depresses polyamine metabolism
Hasheminasabgorji, E., Chen, H., Gatesman, T. A., Younes, S. T., Nobles, G., Jaryani, F., Mao, H., Yu, K., Deneen, B., Yong, V. W., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02141-6 · Cited by 2
Self-citationEZHIP in Pediatric Brain Tumors: From Epigenetic Mimicry to Therapeutic Vulnerabilities
Servidei, T., Gentile, S., Sgambato, A., & Ruggiero, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020963 · Cited by 2
Dominant clones leverage developmental epigenomic states to drive ependymoma
Kardian, A., Sun, H., Ippagunta, S. M., Laboe, N., Varadharajan, S., Yu, K., Chen, H., Emanus, E., Zheng, T., Deneen, R. M., et al. (2026) · Nature · doi:10.1038/s41586-026-10270-8 · Cited by 3
Self-citationReprogramming lipid metabolism in pediatric cancers
Lindemann, V. L., Noureddine, N., & Morscher, R. J. (2026) · Oncogenesis · doi:10.1038/s41389-026-00617-1 · Cited by 2
Bridging the Gaps: iPSC-Based Models from CHIP to MDS to AML
Bernt, K. M. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.02.011 · Cited by 2
Network Approaches for Precision Oncology
Pai, S. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-91836-1_11 · Cited by 2
Corrupted devolution: How normal cells are reborn as cancer precursors
Lord, A. E., & Ficz, G. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106263 · Cited by 2
Montgomery, E. Y., Thirunavu, V. M., Pagadala, M. S., Shlobin, N. A., Plant, A., Lam, S. K., & DeCuypere, M. G. (2022) · Journal of Neurosurgery Pediatrics · doi:10.3171/2022.10.peds22154 · Cited by 2
Wesseling, M., Benavente, E. D., Mokrý, M., den Ruijter, H. M., & Pasterkamp, G. (2024) · Vascular Pharmacology · doi:10.1016/j.vph.2024.107286 · Cited by 2
Highlights from the Literature
Huse, J. T., Abounader, R., Purow, B. W., Hegi, M. E., Soffietti, R., & Aldape, K. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now215 · Cited by 2
Self-citationPersonalized Medicine Through Advanced Genomics
Youngblood, M. W., Erson-Omay, Z., & Günel, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-49864-5_3 · Cited by 2
Transposase-driven rearrangements in human tumors
Mack, S. C., Suzuki, H., & Taylor, M. D. (2017) · Nature Genetics · doi:10.1038/ng.3908 · Cited by 2
Self-citationCancer research: quo vadis—to war?
Wheatley, D. N. (2014) · ecancermedicalscience · doi:10.3332/ecancer.2014.ed45 · Cited by 2
Recent Advancements in Ependymoma: Challenges and Therapeutic Opportunities
Bertrand, K. C., & Klimo, P. D. (2023) · Pediatric Neurosurgery · doi:10.1159/000530868 · Cited by 2
Self-citationDubuc, A. M., & Ligon, A. H. (2017) · Current Genetic Medicine Reports · doi:10.1007/s40142-017-0127-4 · Cited by 2
Self-citationToward an integrated histomolecular diagnosis of supratentorial ependymoma
Pajtler, K. W. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now054 · Cited by 2
Kulasingam, V., & Diamandis, E. P. (2018) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.027557 · Cited by 1
Epigenomic Sequencing Technologies
Chen, J., Keshavarzian, T., & Lupien, M. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837674916-00109 · Cited by 1
Self-citationBasic Science of Pediatric Brain Tumors
Taccone, M. S., Srikanthan, D., Rutka, J. T., & Ramaswamy, V. (2024) · Springer eBooks · doi:10.1007/978-3-031-62017-1_7 · Cited by 1
Self-citationProgress Toward Epigenetic Targeted Therapies for Childhood Cancer
Liapodimitri, A., Tetens, A. R., Craig-Schwartz, J., Lunsford, K., Skalitzky, K. O., & Koldobskiy, M. A. (2024) · Cancers · doi:10.3390/cancers16244149 · Cited by 2
Emerging interventional treatments in the management of pediatric brain tumors
Shatara, M., Ho, W. S., Roland, J. L., & Limbrick, D. D. (2025) · Advances in cancer research · doi:10.1016/bs.acr.2025.09.004 · Cited by 1
The Main Cancer Theories in Focus
Paul, D. (2025) · Springer eBooks · doi:10.1007/978-3-032-08808-6_5 · Cited by 1
Advances in cancer biomarkers: Diagnostic, prognostic, and therapeutic implications
Madhuranga, H. D. T., Joseph, R., Madhan, G., Sarvananda, L., & Premarathna, A. D. (2026) · The Journal of Precision Medicine Health and Disease · doi:10.1016/j.premed.2026.100032 · Cited by 1
Biswas, K., Ghosh, S., Khincha, P. P., Sundby, R. T., Singh, A., Ault, G. S., Henderson, M. J., Gross, A. M., Donoghue, M. B., Savage, S. A., et al. (2026) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djag068 · Cited by 1
Personalized Medicine and Epigenetic Drug Development
Lundstrom, K. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420135-4.00013-9 · Cited by 1
External signals shape the epigenome
Lennartsson, A. (2016) · Genome biology · doi:10.1186/s13059-016-0884-5 · Cited by 1
Natural Killer Cells: A Potential Therapy for Paediatric Brain Tumours
Fujii, C. F. H. (2015) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000209 · Cited by 1
Yang, Z., Jia, M., Liu, G., Hao, H., Chen, L., Li, G., Liu, S., Li, Y., Wu, C., Lu, X., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187551 · Cited by 1
Gorsi, H. S., Toll, S. A., Sood, S., Miler, S., Altinok, D., Kumar‐Sinha, C., Mody, R., & Yankelevich, M. (2021) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002175 · Cited by 1
Induced pluripotent stem cells as the source of cancer stem cells providing novel concepts of cancer
Seno, A., Afify, S. M., Hassan, G., & Seno, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85545-7.00002-8 · Cited by 1
Pediatric posterior fossa ependymoma and metabolism
Halligan, K. E., Michealraj, K. A., Cruz, A. F., Felker, J. T., Daniels, C. E., Taylor, M. D., & Agnihotri, S. (2021) · Glioma · doi:10.4103/glioma.glioma_17_21 · Cited by 1
Self-citationVillar, R. C., & Merchant, T. E. (2018) · Pediatric oncology · doi:10.1007/978-3-319-43545-9_12 · Cited by 1
Witt, H., & Pajtler, K. W. (2018) · Springer eBooks · doi:10.1007/978-3-319-43205-2_8 · Cited by 1
Self-citationYiallouros, M. (2007) · doi:10.1591/poh.patinfo.ependy.kurz.1.20070626 · Cited by 1
Pediatric CNS cancer genomics and immunogenomics
Miller, K. E., & Mardis, E. R. (2022) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2022.101918 · Cited by 2
Primary Pediatric Brain Tumors of the Posterior Fossa: Part I
Felton, K. E. A., Hogg, A., Liang, L., Aiken, C., Klonisch, T. C., van Landeghem, F. K. H., Werbowetski‐Ogilvie, T. E., & Eisenstat, D. D. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-23104-9_18 · Cited by 1
“Soap bubble” sign as an imaging marker for posterior fossa ependymoma Group B
Jin, Y., Cheng, D., Duan, Y., Zhuo, Z., Weng, J., Zhang, C., Zhu, M., Liu, X., Du, J., Hua, T., et al. (2023) · Neuroradiology · doi:10.1007/s00234-023-03231-9 · Cited by 1
Comprehensive Review of Primary Posterior Fossa Tumors in Children
Aydın, S., Yalçın, K. O., Butasın, R., & Perçinoğlu, G. (2023) · European Archives of Medical Research · doi:10.4274/eamr.galenos.2023.02693 · Cited by 1
A possible role for epigenetics in cancer initiation
Martinez, A., & Cavalli, G. (2025) · Comptes Rendus Biologies · doi:10.5802/crbiol.171 · Cited by 1
Prognostic factors in ependymal tumors: Molecular biology trumps histopathology
Moiyadi, A. V., Gupta, T., & Epari, S. (2016) · Neurology India · doi:10.4103/0028-3886.177599 · Cited by 1
Molecular Biology of Human Brain Tumors
Coluccia, D., Weeks, A., Fandino, J., Schneider, C., Smith, C. A., & Rutka, J. T. (2016) · Springer eBooks · doi:10.1007/978-1-59745-458-2_35 · Cited by 1
Self-citation
Metadata
- Authors
- Mack, S. C., Witt, H., Piro, R. M., Gu, L., Zuyderduyn, S., Stütz, A. M., Wang, X., Gallo, M., Garzia, L., Zayne, K., Zhang, X., Ramaswamy, V., Jäger, N., Jones, D. T. W., Sill, M., Pugh, T. J., Ryzhova, M., Wani, K. M., Shih, D. J. H., Head, R., Remke, M., Bailey, S. D., Zichner, T., Faria, C. C., Barszczyk, M., Stark, S., Seker-Cin, H., Hutter, S., Johann, P., Bender, S., Hovestadt, V., Tzaridis, T., Dubuc, A. M., Northcott, P. A., Peacock, J., Bertrand, K. C., Agnihotri, S., Cavalli, F. M. G., Clarke, I., Nethery-Brokx, K., Creasy, C. L., Verma, S. K., Koster, J., Wu, X., Yao, Y., Milde, T., Sin-Chan, P., Zuccaro, J., Lau, L., Pereira, S., Castelo-Branco, P., Hirst, M., Marra, M. A., Roberts, S. S., Fults, D., Massimi, L., Cho, Y. J., Van Meter, T., Grajkowska, W., Lach, B., Kulozik, A. E., von Deimling, A., Witt, O., Scherer, S. W., Fan, X., Muraszko, K. M., Kool, M., Pomeroy, S. L., Gupta, N., Phillips, J., Huang, A., Tabori, U., Hawkins, C., Malkin, D., Kongkham, P. N., Weiss, W. A., Jabado, N., Rutka, J. T., Bouffet, E., Korbel, J. O., Lupien, M., Aldape, K. D., Bader, G. D., Eils, R., Lichter, P., Dirks, P. B., Pfister, S. M., Korshunov, A., & Taylor, M. D.
- Affiliations
- University of Toronto (CA)
- German Cancer Research Center (DE)
- European Molecular Biology Laboratory (DE)
- Hospital for Sick Children (CA)
- Dartmouth–Hitchcock Medical Center (US)
- Boston Children's Hospital (US)
- The University of Texas MD Anderson Cancer Center (US)
- Ontario Institute for Cancer Research (CA)
- GlaxoSmithKline (United States) (US)
- BC Cancer Agency (CA)
- Uniformed Services University of the Health Sciences (US)
- University of Utah (US)
- Agostino Gemelli University Polyclinic (IT)
- Stanford Medicine (US)
- Children's Memorial Health Institute (PL)
- Hamilton General Hospital (CA)
- Heidelberg University (DE)
- University of Michigan (US)
- University of California, San Francisco (US)
- McGill University Health Centre (CA)
- Corresponding author
- Korshunov, A.
- Taylor, M. D.
- ORCID
- Mack, S. C.
- Witt, H.
- Piro, R. M.
- Gu, L.
- Stütz, A. M.
- Wang, X.
- Gallo, M.
- Garzia, L.
- Zhang, X.
- Ramaswamy, V.
- Jäger, N.
- Jones, D. T. W.
- Sill, M.
- Pugh, T. J.
- Ryzhova, M.
- Wani, K. M.
- Shih, D. J. H.
- Remke, M.
- Bailey, S. D.
- Zichner, T.
- Faria, C. C.
- Barszczyk, M.
- Hutter, S.
- Johann, P.
- Hovestadt, V.
- Tzaridis, T.
- Dubuc, A. M.
- Northcott, P. A.
- Bertrand, K. C.
- Agnihotri, S.
- Cavalli, F. M. G.
- Creasy, C. L.
- Verma, S. K.
- Wu, X.
- Yao, Y.
- Milde, T.
- Zuccaro, J.
- Lau, L.
- Pereira, S.
- Hirst, M.
- Marra, M. A.
- Roberts, S. S.
- Fults, D.
- Massimi, L.
- Cho, Y. J.
- Grajkowska, W.
- Lach, B.
- Kulozik, A. E.
- Witt, O.
- Scherer, S. W.
- Fan, X.
- Muraszko, K. M.
- Kool, M.
- Pomeroy, S. L.
- Gupta, N.
- Phillips, J.
- Huang, A.
- Tabori, U.
- Hawkins, C.
- Malkin, D.
- Kongkham, P. N.
- Weiss, W. A.
- Jabado, N.
- Rutka, J. T.
- Korbel, J. O.
- Lupien, M.
- Aldape, K. D.
- Bader, G. D.
- Eils, R.
- Lichter, P.
- Dirks, P. B.
- Pfister, S. M.
- Korshunov, A.
- Taylor, M. D.
- Venue
- Nature
- Published
- 2014-02
- Volume
- 506
- Issue
- 7489
- Pages
- 445-450
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4174313
- OpenAlex
- W2113432767
- Cited by
- 607
- References
- 50
- Citations by year
- 2026: 15 · 2025: 29 · 2024: 30 · 2023: 29 · 2022: 37 · 2021: 51 · 2020: 56 · 2019: 55 · 2018: 68 · 2017: 64 · 2016: 73 · 2015: 57 · 2014: 40
- FWCI
- 39.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Pediatric Brain Tumor Foundation
- CureSearch for Children's Cancer
- Deutsches Krebsforschungszentrum
- Government of Ontario
- Bundesministerium für Bildung und Forschung (01KU1201A, 01GS0883)
- Terry Fox Research Institute
- Deutsche Krebshilfe (109252)
- Deutschen Konsortium für Translationale Krebsforschung
- National Institutes of Health
- Canadian Institutes of Health Research
- National Cancer Institute (R01CA148699, R01CA148621, R01CA121941, R01CA163737, R01CA159859, P30CA016672, P50CA097257)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- ependymoma, CpG island methylator phenotype, pediatric brain tumors, C11orf95-RELA fusion, chromothripsis, NF-κB signaling, H3K27me3, polycomb repressive complex 2, DNA methylation, EZH2 inhibitors, epigenetic therapy, tumor suppressor
- MeSH terms
- Animals, Brain Neoplasms, Ependymoma, Female, Histones, Humans, Infant, Mutation, Phenotype, Prognosis, Rhombencephalon, Gene Expression Regulation, Neoplastic, Mice, SCID, Mice, Inbred NOD, CpG Islands, DNA Methylation, Gene Silencing, Xenograft Model Antitumor Assays, Epigenesis, Genetic, Mice, Embryonic Stem Cells, Epigenomics, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
